Michael Pine
Corporate Officer/Principal chez EYEPOINT PHARMACEUTICALS, INC.
Fortune : 220 778 $ au 30/04/2024
Provenance du réseau au premier degré de Michael Pine
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 19 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Michael Pine via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| C.R. BARD | Medical Specialties | Corporate Officer/Principal | |
| JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INOTIV, INC. | Miscellaneous Commercial Services | Chairman | |
| INTERPACE BIOSCIENCES, INC. | Medical Specialties | Chief Executive Officer Human Resources Officer | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
KBI Biopharma, Inc.
 KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
SWMF Life Science Venture Fund LP
 SWMF Life Science Venture Fund LP Investment ManagersFinance SWMF Life Science Venture Fund LP invests in life science and medical device companies located in Southwest Michigan. It provides financing for start-up and early stage capital requirements. | Investment Managers | Chairman | |
Metabolic Solutions Development Co. LLC
 Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI. | Pharmaceuticals: Generic | Director/Board Member | |
| db-X ETF Trust | Investment Trusts/Mutual Funds | Director/Board Member | |
EDB Investments Pte Ltd.
 EDB Investments Pte Ltd. Investment ManagersFinance EDB Investments Pte Ltd (EDB Investments) is a Venture Capital firm founded in 1991. The firm is headquartered in Singapore. | Investment Managers | Consultant / Advisor | |
| Kent State University (Ohio) | College/University | Undergraduate Degree | |
| Pace University | College/University | Undergraduate Degree | |
| Purdue University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| University of Uppsala | College/University | Undergraduate Degree | |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Glaxo Group Ltd.
 Glaxo Group Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1935, Glaxo Group Ltd. is a subsidiary of GSK Plc. The company is based in Middlesex, UK. At GSK, we unite science, technology and talent to get ahead of disease together. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Doctorate Degree | |
| RAND Health | Director/Board Member | ||
Archimedes Pharma UK Ltd.
 Archimedes Pharma UK Ltd. Medical/Nursing ServicesHealth Services Archimedes Pharma UK Ltd. involves in marketing niche pharmaceutical products. The company is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| Essex Woodlands Health Ventures UK Ltd. | Investment Managers | Corporate Officer/Principal | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member | |
American College of Rheumatology
 American College of Rheumatology Miscellaneous Commercial ServicesCommercial Services The American College of Rheumatology is an organization for physicians and health professionals. The non-profit company is based in Atlanta, GA. The company was founded by Göran Albert Torstensson Ando. | Miscellaneous Commercial Services | Founder | |
| CELLDEX THERAPEUTICS, INC. | Medical/Nursing Services | Director/Board Member | |
| Pfizer International LLC | Chief Tech/Sci/R&D Officer | ||
Celldex Research Corp.
 Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Celldex Research Corp. engages in provision of biological research and development. The company is headquartered in Phillipsburg, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
Jazz Pharmaceuticals UK Ltd.
 Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Pricewaterhousecoopers LLC | Corporate Officer/Principal | ||
| Chatham Street Partners | Founder | ||
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Medical Distributors | Director/Board Member | |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman | |
| Pdi, Inc. (United States) | Chief Executive Officer Chief Tech/Sci/R&D Officer | ||
Oncology Venture US, Inc.
 Oncology Venture US, Inc. Miscellaneous Commercial ServicesCommercial Services Oncology Venture US, Inc. develops therapies for cancer treatment. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Enzyvant, Inc.
 Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Enzyvant, Inc. develops biopharmaceutical products. The company is based in Cambridge, MA. William T. Symonds has been the CEO of the company since 2022. | Pharmaceuticals: Major | Chief Executive Officer | |
Enzyvant Therapeutics, Inc.
 Enzyvant Therapeutics, Inc. BiotechnologyHealth Technology Enzyvant Therapeutics, Inc. develops biopharmaceutical products. It focuses on developing transformative therapies for rare diseases with high unmet needs. The company is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO | |
| Nouscom Srl | Miscellaneous Commercial Services | Chairman | |
Eyebiotech Ltd.
 Eyebiotech Ltd. BiotechnologyHealth Technology Eyebiotech Ltd. develops new generation of therapies for eye diseases. The British company was founded in 2021 by David R. Guyer, Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Biotechnology | Chief Executive Officer Founder |
Statistiques
Internationale
| Etats-Unis | 35 |
| Royaume-Uni | 8 |
| Suisse | 4 |
| Danemark | 3 |
| Suède | 3 |
Sectorielle
| Health Technology | 27 |
| Commercial Services | 7 |
| Consumer Services | 6 |
| Finance | 4 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 109 |
| Corporate Officer/Principal | 52 |
| Independent Dir/Board Member | 35 |
| Chairman | 24 |
| Chief Executive Officer | 18 |
Relations les plus connectées
| Insiders | |
|---|---|
| Göran Albert Ando | 44 |
| Wendy DiCicco | 30 |
| David Guyer | 27 |
| Ronald Eastman | 24 |
| Nancy Lurker | 20 |
| George Elston | 18 |
| John Landis | 15 |
| Karen Zaderej | 12 |
| Anthony Adamis | 12 |
| Jay Duker | 9 |
| Ron I. Honig | 8 |
| Stuart Duty | 8 |
| Dario Paggiarino | 8 |
| Jennifer Leonard | 7 |
| John Weet | 7 |
- Bourse
- Insiders
- Michael Pine
- Connexions Sociétés
